June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Last results of the Spanish Multicenter Genetic Glaucoma Group
Author Affiliations & Notes
  • Elena Milla
    Institut Comtal d'Oftalmologia and Hospital Clinic, Barcelona, Spain
    Spanish Multicenter Genetic Glaucoma Group, 18 Spanish Eye Centers, Spain, Spain
  • Susana Duch
    Glaucoma, Institut Comtal d'Oftalmologia, Barcelona, Spain
  • Miguel Carballo
    Hospital de Terrassa, Barcelona, Spain
  • Maria Jose Gamundi
    Hospital de Terrassa, Barcelona, Spain
  • Footnotes
    Commercial Relationships Elena Milla, None; Susana Duch, None; Miguel Carballo, None; Maria Jose Gamundi, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6218. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elena Milla, Susana Duch, Miguel Carballo, Maria Jose Gamundi; Last results of the Spanish Multicenter Genetic Glaucoma Group. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6218.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: clinical and genetic characterization of unrelated Spanish patients affected by glaucoma coming from different parts of Spain.

Methods: all individuals underwent complete ophthalmologic examination. Screening for mutations in MYOC and CYP1B1 by direct genomic sequencing was performed in 302 families affected with different forms of glaucoma.

Results: We identified one novel MYOC mutation in a primary open angle glaucoma family, and five previously reported MYOC mutations in seven families affected by different subtypes of glaucoma. Three novel CYP1B1 mutations were described and thirteen known mutations found in patients mainly with primary congenital glaucoma.

Conclusions: We think that the high rate of CYP1B1 mutations found in (33.3%) our congenital glaucoma patients makes its genetic testing mandatory. The rate of MYOC mutations was similar to the one reported in the literature. The genetic diagnostic of our glaucoma patients was regarded as a useful tool in order to modulate their treatment.

Keywords: 539 genetics  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.